{"name": "Oxford Immunotec",
 "permalink": "oxford-immunotec",
 "crunchbase_url": "http://www.crunchbase.com/company/oxford-immunotec",
 "homepage_url": "http://www.oxfordimmunotec.com",
 "blog_url": "http://www.facebook.com/home.php?#/pages/TB-Test/276050850106",
 "blog_feed_url": "",
 "twitter_username": "TBDiagnosis",
 "category_code": "biotech",
 "number_of_employees": 79,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "tb-test, tb-testing, tb-diagnosis, tb-diagnostics, tuberculosis-test, test-for-tuberculosis, t-spot, t-spot-tb, igra, igras, interferon-gamma-release-assay, latent-tb, tb-screening, tb-skin-test, mantoux, tuberculosis, tb",
 "alias_list": "",
 "email_address": "marketing@oxfordimmunotec.com",
 "phone_number": "+44(0)1235 442780",
 "description": "TB Testing Company",
 "created_at": "Thu Nov 26 15:06:17 UTC 2009",
 "updated_at": "Tue Jun 19 02:51:11 UTC 2012",
 "overview": "\u003Cp\u003EOxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company\u0026#8217;s first product is a TB test that diagnoses latent TB  infection ( LTBI ) and TB disease. T-SPOT\u00c2\u00ae.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).  \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       60],
      "assets/images/resized/0007/1001/71001v2-max-150x150.jpg"],
     [[241,
       97],
      "assets/images/resized/0007/1001/71001v2-max-250x250.jpg"],
     [[241,
       97],
      "assets/images/resized/0007/1001/71001v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Peter",
      "last_name": "Wrighton-Smith",
      "permalink": "peter-wrighton-smith",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Richard",
      "last_name": "M. Altieri",
      "permalink": "richard-m-altieri",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$101M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.oxfordimmunotec.com/Default.aspx?DN=f673006f-0d53-4065-b191-e485e3981ae5",
    "source_description": "Oxford Immunotec Completes $40M Financing",
    "raised_amount": 40000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 10,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wellington Partners",
         "permalink": "wellington-partners",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0001/9753/19753v1-max-150x150.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-250x250.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "NTEC",
         "permalink": "ntec",
         "image":
          {"available_sizes":
            [[[86,
               86],
              "assets/images/resized/0025/6628/256628v1-max-150x150.png"],
             [[86,
               86],
              "assets/images/resized/0025/6628/256628v1-max-250x250.png"],
             [[86,
               86],
              "assets/images/resized/0025/6628/256628v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Prelude Trust",
         "permalink": "prelude-trust",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quester Capital",
         "permalink": "quester-capital",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0025/2082/252082v1-max-150x150.png"],
             [[250,
               47],
              "assets/images/resized/0025/2082/252082v1-max-250x250.png"],
             [[450,
               85],
              "assets/images/resized/0025/2082/252082v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "The Dow Company",
         "permalink": "the-dow-chemical-company",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0009/5549/95549v2-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0009/5549/95549v2-max-250x250.jpg"],
             [[378,
               133],
              "assets/images/resized/0009/5549/95549v2-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://onbiovc.com/oxford-immunotec-ltd-series-d-26m/",
    "source_description": "Oxford Immunotec, Ltd.: Series D $26M",
    "raised_amount": 26000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 5,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kaiser Permanente Ventures",
         "permalink": "kaiser-permanente-ventures",
         "image":
          {"available_sizes":
            [[[150,
               11],
              "assets/images/resized/0005/2717/52717v1-max-150x150.png"],
             [[250,
               19],
              "assets/images/resized/0005/2717/52717v1-max-250x250.png"],
             [[379,
               30],
              "assets/images/resized/0005/2717/52717v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wellington Partners",
         "permalink": "wellington-partners",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0001/9753/19753v1-max-150x150.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-250x250.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Spark Ventures",
         "permalink": "spark-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0003/0860/30860v1-max-150x150.jpg"],
             [[190,
               91],
              "assets/images/resized/0003/0860/30860v1-max-250x250.jpg"],
             [[190,
               91],
              "assets/images/resized/0003/0860/30860v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "DFJ Esprit",
         "permalink": "dfj-esprit",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0002/3532/23532v1-max-150x150.png"],
             [[231,
               91],
              "assets/images/resized/0002/3532/23532v1-max-250x250.png"],
             [[231,
               91],
              "assets/images/resized/0002/3532/23532v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Oxford University",
         "permalink": "oxford-university",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0003/0408/30408v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0003/0408/30408v1-max-250x250.png"],
             [[251,
               78],
              "assets/images/resized/0003/0408/30408v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.accessmylibrary.com/article-1G1-135240693/oxford-immunotec-gets-7m.html",
    "source_description": "Oxford Immunotec gets 7m [pounds sterling] to broaden reach of TB test.",
    "raised_amount": 7000000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2005,
    "funded_month": 8,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Prelude Trust",
         "permalink": "prelude-trust",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quester Capital",
         "permalink": "quester-capital",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0025/2082/252082v1-max-150x150.png"],
             [[250,
               47],
              "assets/images/resized/0025/2082/252082v1-max-250x250.png"],
             [[450,
               85],
              "assets/images/resized/0025/2082/252082v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "The Dow Company",
         "permalink": "the-dow-chemical-company",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0009/5549/95549v2-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0009/5549/95549v2-max-250x250.jpg"],
             [[378,
               133],
              "assets/images/resized/0009/5549/95549v2-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2012/06/oxford-immunotec-raises-28m-equity-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Oxford Immunotec Raises $28M in Equity Financing",
    "raised_amount": 28000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 6,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Imperial Innovations",
         "permalink": "imperial-innovations",
         "image":
          {"available_sizes":
            [[[65,
               150],
              "assets/images/resized/0004/6361/46361v1-max-150x150.jpg"],
             [[108,
               250],
              "assets/images/resized/0004/6361/46361v1-max-250x250.jpg"],
             [[193,
               445],
              "assets/images/resized/0004/6361/46361v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Invesco Perpetual",
         "permalink": "invesco-perpetual",
         "image":
          {"available_sizes":
            [[[110,
               80],
              "assets/images/resized/0010/2340/102340v2-max-150x150.jpg"],
             [[110,
               80],
              "assets/images/resized/0010/2340/102340v2-max-250x250.jpg"],
             [[110,
               80],
              "assets/images/resized/0010/2340/102340v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "DFJ Esprit",
         "permalink": "dfj-esprit",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0002/3532/23532v1-max-150x150.png"],
             [[231,
               91],
              "assets/images/resized/0002/3532/23532v1-max-250x250.png"],
             [[231,
               91],
              "assets/images/resized/0002/3532/23532v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wellington Partners",
         "permalink": "wellington-partners",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0001/9753/19753v1-max-150x150.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-250x250.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Spark Ventures",
         "permalink": "spark-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0003/0860/30860v1-max-150x150.jpg"],
             [[190,
               91],
              "assets/images/resized/0003/0860/30860v1-max-250x250.jpg"],
             [[190,
               91],
              "assets/images/resized/0003/0860/30860v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kaiser Permanente Ventures",
         "permalink": "kaiser-permanente-ventures",
         "image":
          {"available_sizes":
            [[[150,
               11],
              "assets/images/resized/0005/2717/52717v1-max-150x150.png"],
             [[250,
               19],
              "assets/images/resized/0005/2717/52717v1-max-250x250.png"],
             [[379,
               30],
              "assets/images/resized/0005/2717/52717v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Oxford Immunotec HQ",
    "address1": "115D Milton Park",
    "address2": "Abingdon",
    "zip_code": "OX14 4RZ",
    "city": "Oxfordshire",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null},
   {"description": "Oxford Immunotec D\u0026M",
    "address1": "94C Milton Park",
    "address2": "Abingdon",
    "zip_code": "OX14 4RY",
    "city": "Oxfordshire",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null},
   {"description": "Oxford Immunotec Inc.",
    "address1": "2 Mount Royal Avenue, Suite 100",
    "address2": "",
    "zip_code": "MA 01792",
    "city": "Marlborough",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        91],
       "assets/images/resized/0007/9922/79922v1-max-150x150.jpg"],
      [[250,
        152],
       "assets/images/resized/0007/9922/79922v1-max-250x250.jpg"],
      [[450,
        275],
       "assets/images/resized/0007/9922/79922v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  [{"external_url": "http://www.learntb.com",
    "title": "The Learning Zone"}]}